trending research reports

The global  tetanus toxoid vaccine market  size is anticipated to reach USD 8.09 billion by 2030 and is expected to expand at a CAGR of 5.67% from 2025 to 2030, according to a new report by Grand View Research, Inc. The tetanus toxoid vaccine industry is witnessing significant growth due to the increasing focus on immunization programs and rising awareness about vaccine-preventable diseases. Tetanus, a severe bacterial infection affecting the nervous system, remains a global health concern, particularly in regions with low vaccination coverage. The expanding adoption of vaccination drives and improved healthcare infrastructure are key factors propelling market expansion. A major contributor to market growth is the availability of combination vaccines, which provide broader protection against multiple diseases. The Diphtheria, Tetanus, and Pertussis (DTaP) vaccine is widely administered in pediatric immunization schedules, ensuring early protection against these s...

The global  hemostasis diagnostics market  size is expected to reach USD 1.49 billion by 2030, registering a CAGR of 4.5% from 2025 to 2030, according to a new report by Grand View Research, Inc. The market is likely to show significant growth due to various factors, such as the growing geriatric population across the globe, advancements in diagnostic technologies, increasing awareness of bleeding and clotting disorders, and the rising prevalence of chronic diseases. One of the primary drivers of the market is the growing geriatric population. As people age, the likelihood of developing conditions that affect hemostasis, such as venous thromboembolism, atrial fibrillation, and other cardiovascular diseases, increases. Older individuals are also more likely to undergo surgeries that require accurate monitoring of coagulation levels to avoid complications like excessive bleeding or clot formation. This demographic trend is boosting the demand for diagnostic tools that can asse...

The global  digital surgical microscopes market  size is expected to reach USD 2.15 billion by 2030, registering a CAGR of 11.54% from 2025 to 2030, according to a new report by Grand View Research, Inc. Minimally invasive surgeries are becoming increasingly popular due to their reduced recovery times, lower risk of complications, and improved patient outcomes. Digital surgical microscopes play a crucial role in these procedures by providing detailed, high-resolution imaging that enhances visualization in confined surgical fields. Their ability to integrate seamlessly with robotic systems further boosts their adoption of minimally invasive techniques. This growing preference for advanced surgical solutions is a significant driver of market growth. The market is experiencing significant growth, primarily driven by technological advancements. Innovations such as 3D visualization, augmented reality (AR) integration, and AI-powered imaging systems have revo...

The global  non-viral gene delivery technologies market  size is anticipated to reach USD 7.11 billion by 2030 and grow at a CAGR of 12.29% from 2025 to 2030 during the forecast period, according to a new report by Grand View Research, Inc. The market's growth is driven by the growing demand for safe, scalable, and cost-effective alternatives to viral vectors in gene therapy and research. Unlike viral methods, non-viral technologies such as lipid nanoparticles (LNPs), polymers, and electroporation offer lower immunogenicity and reduced manufacturing complexities. These attributes make them highly suitable for large-scale applications, including mRNA-based vaccines and CRISPR/Cas9-based gene editing therapies. The success of mRNA COVID-19 vaccines by Moderna and Pfizer-BioNTech further validated the potential of non-viral delivery systems, spurring global investment in this sector. Advancements in nanotechnology and biomaterials are further accelerating i...

The global Human Liver Model Market is entering a transformative era, projected to grow from USD 1.34 billion in 2024 to over USD 3 billion by 2030 , expanding at a CAGR of 14.04% , this surge is driven by the rising prevalence of liver diseases, breakthroughs in 3D bioprinting, and the urgent need for more accurate drug testing platforms. Why Liver Models Matter Human liver models are revolutionizing biomedical research by offering human-relevant alternatives to animal testing . These models are used extensively in: ADME studies (Absorption, Distribution, Metabolism, and Excretion) Toxicology testing Disease modeling Personalized medicine With liver diseases such as non-alcoholic fatty liver disease (NAFLD) affecting nearly 25% of the global population , the demand for precise, scalable liver models has never been higher. Innovation at the Core Recent advances in organ-on-chip technology , stem cell research , and 3D bioprinting have enabled the creation of liver models that ...

The global topical hemostat market is experiencing a dramatic upswing, with its valuation reaching USD 5.9 billion in 2024 and projected to grow at a CAGR of 9.4% through 2030 . This surge is fueled by rising surgical volumes, increasing trauma cases, and groundbreaking advancements in hemostatic technologies. Market Momentum: What’s Driving the Growth? Topical hemostats-agents applied directly to bleeding sites-are becoming indispensable in modern surgical procedures. Their ability to control bleeding swiftly and safely makes them vital in cardiovascular, orthopedic, and neurosurgical operations . Key growth drivers include: Rising global surgical procedures and trauma incidents Demand for faster wound healing and reduced complications Expansion of healthcare infrastructure in emerging markets Shift toward minimally invasive surgeries Innovation Spotlight: Nature-Inspired Hemostats One of the most exciting developments in the field is a bilayer nanofiber membrane hemostat d...

The global bone punches market is entering a dynamic phase of expansion, driven by the rising prevalence of orthopedic conditions and the growing demand for precision surgical tools, the market was valued at USD 198.30 million in 2024 and is projected to grow at a CAGR of 4.13% from 2025 to 2030. Market Drivers: Aging Population & Surgical Innovation The surge in orthopedic surgeries-spurred by aging demographics, sports injuries, and trauma cases-is fueling demand for bone punches. These instruments are essential in procedures such as fracture repair, joint replacements, and spinal surgeries. With the World Health Organization forecasting that 1 in 6 people will be aged 60 or older by 2030, the need for reliable and precise surgical tools is more urgent than ever. Product Evolution: From Classic to Cutting-Edge The market is segmented by product types including: Classical Kerrison Punches Detachable Kerrison Punches Noir Kerrison Punches These tools are evolving to me...

The global surgical robot systems market is entering a transformative era, with cutting-edge technology reshaping the future of surgery. the market was valued at USD 11.48 billion in 2024 and is projected to reach USD 23.13 billion by 2030 , growing at a robust CAGR of 12.4% from 2025 to 2030. Driving Forces: Innovation Meets Demand The market’s rapid growth is fueled by: Rising demand for minimally invasive procedures Improved surgical outcomes and reduced complications Technological advancements in robotic precision and control Robotic systems are enabling surgeons to perform complex procedures through small incisions with unmatched accuracy, reducing recovery time and enhancing patient safety. Market Segmentation Highlights By Component: Surgical robotic accessories dominated with a 47.6% revenue share in 2024 By Application: Orthopedics led with 22.5% share, followed by neurology and gastrointestinal surgeries By End-Use: Hospitals and clinics remain the primary adopters, wh...

The global  human metapneumovirus diagnostics market  size is anticipated to reach USD 971.30 million by 2030 and is projected to grow at a CAGR 10.43% from 2025 to 2030, according to a new report by Grand View Research, Inc. The human metapneumovirus (hMPV) diagnostics market is experiencing significant growth, driven by the increasing prevalence of respiratory infections caused by hMPV, particularly among vulnerable populations such as children, the elderly, and immunocompromised individuals. hMPV is known to cause respiratory illnesses similar to those caused by influenza and respiratory syncytial virus (RSV), including bronchiolitis, pneumonia, and upper respiratory tract infections. As awareness about hMPV’s role in respiratory diseases increases, there is a growing demand for effective diagnostic solutions, contributing to the market’s expansion. Key drivers of this market include advancements in diagnostic technologies, rising healthcare spending, and the ...

The global patient positioning and support aids market hit approximately USD 1.62 billion in 2024 and is slated for a robust climb-with a CAGR of 7.1% -through 2030 . This isn’t some gradual plateau-it’s a clear sprint fueled by a convergence of need and innovation. What’s Fueling the Growth? Aging populations & chronic disease surge : Older demographics and the rising prevalence of chronic conditions are increasing the demand, particularly in surgical and post-op settings. Surgical volume explosion : Hundreds of millions of surgeries happen every year globally-and these procedures need advanced positioning aids like slide sheets, wedges, fluidized and gel positioners to mitigate pressure injuries and support safe transfers. Tech-forward products : Today's tools aren’t just foam and fabric. Think anti-skid strips, integrated arm protectors, smart labels, safety straps-and patented systems like the SurgyPad that are earning GPO contracts and surgeon kudos. Hospital-ac...

The global urology ultrasound devices market surged to an estimated USD 1.21 billion in 2024 and is projected to reach approximately USD 1.29 billion in 2025 , before climbing to USD 1.74 billion by 2030 , a steady CAGR of 6.17% for the 2025-2030 period. What’s driving this momentum? The growing prevalence of urological disorders -from prostate cancer and benign prostatic hyperplasia (BPH) to kidney stones-especially in aging populations. Innovations like AI-enhanced imaging and portable/hand-held devices are making diagnostics faster, smarter, and more accessible. Spotlight Segments: Prostate Leads, Diagnostics Shifts, and Regions to Watch Prostate Disorders: Clear Front-Runner The prostate disorders segment accounted for the largest share at 36.8% in 2024 , and it's also expected to grow the fastest-driven by aging male demographics and rising diagnosis rates. Diagnostics Centers: A Rapid Move Diagnostic imaging centers will see the fastest growth among end-use segments, w...

The global  veterinary oncology diagnostics market  is expected to reach USD 3.45 billion by 2030, registering a CAGR of 8.4% from 2025 to 2030, according to a new report by Grand View Research, Inc. The market is primarily driven by growing animal population and ownership rates, increased expenditure on animals, shifting focus on preventative animal healthcare, advances in veterinary cancer diagnostic testing, and rising R&D investment in animal health diagnostics to launch innovative products. For instance, in December 2024, Pet Preferred Diagnostics introduced a groundbreaking early cancer diagnostic test for dogs and cats that detects 11 specific onconeural antibodies linked to 21 types of tumors and 14 neurological diseases. This highly sensitive serological test can identify malignancy, often before clinical signs appear, enabling early treatment. It is the only test available in veterinary medicine that differentiates various tumors and neurological co...